Advancements in Tissue Viability Assessment and Regenerative Strategies for Enhanced Burn Wound Healing

Abstract

Burn injuries represent a significant clinical challenge, often leading to extensive tissue damage and impaired healing. Accurate assessment of tissue viability is crucial for guiding clinical decision-making and optimizing treatment strategies. This research report provides a comprehensive overview of tissue damage caused by burns, the intricate biological processes underlying tissue healing and regeneration, and various methods employed for assessing tissue viability, including traditional techniques and advanced imaging modalities. Furthermore, it explores the potential of regenerative medicine approaches, such as growth factors, cell-based therapies, and biomaterials, to enhance tissue repair and reduce scarring in burn injuries. Special attention is given to the DeepView system and other emerging technologies aimed at objective and quantitative assessment of wound healing progress. This report aims to provide a valuable resource for clinicians, researchers, and engineers interested in advancing the field of burn wound management.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

1. Introduction

Burn injuries are a major cause of morbidity and mortality worldwide, resulting in significant functional and aesthetic deficits. The extent and depth of tissue damage determine the severity of the burn and subsequent clinical course. Effective burn wound management requires a multi-faceted approach, including early resuscitation, infection control, meticulous wound care, and, in many cases, surgical intervention. A critical aspect of burn wound care is the accurate assessment of tissue viability to distinguish between viable, partially viable, and necrotic tissue. This differentiation guides debridement strategies, influences the selection of wound dressings, and informs decisions regarding skin grafting or other reconstructive procedures. Historically, clinical assessment, based on visual inspection and tactile examination, has been the primary method for evaluating tissue viability. However, clinical assessment is subjective and can be unreliable, particularly in the early stages after injury. This has driven the development of advanced imaging techniques and biomarkers to provide more objective and quantitative assessments of tissue perfusion and cellular function. Furthermore, the limitations of conventional wound healing have fueled research into regenerative medicine approaches that aim to stimulate tissue repair and minimize scarring. These approaches harness the body’s natural healing capabilities through the application of growth factors, cell-based therapies, and biomaterials.

This report will delve into the various aspects of tissue damage caused by burns, the biological mechanisms of wound healing, methods for assessing tissue viability, and the potential of regenerative medicine to improve outcomes for burn patients. The report will consider the DeepView system as one of the technologies used to assess tissue damage.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

2. Types of Tissue Damage in Burn Injuries

Burn injuries cause a spectrum of tissue damage, ranging from superficial epidermal burns to deep burns involving the subcutaneous tissue, muscle, and even bone. The extent of tissue damage is determined by several factors, including the temperature of the heat source, the duration of exposure, and the type of tissue involved. Three zones of injury have been described in the pathophysiology of burn wounds:

• Zone of Coagulation: This is the central area of the burn wound where the most severe damage has occurred. Tissue in this zone is irreversibly damaged and necrotic due to protein denaturation, cellular lysis, and microvascular thrombosis. This zone is characterized by complete loss of blood flow and is often visibly charred or coagulated.
• Zone of Stasis: This zone surrounds the zone of coagulation and is characterized by impaired microcirculation and inflammation. Tissue in this zone is potentially salvageable, but it is vulnerable to further damage from ischemia, infection, and inflammation. The fate of tissue in the zone of stasis is highly dependent on early and appropriate intervention, including adequate resuscitation, infection control, and optimization of local wound care. Without appropriate management, the zone of stasis can convert to the zone of coagulation, expanding the area of necrosis.
• Zone of Hyperemia: This is the outermost zone, characterized by increased blood flow and inflammation. Tissue in this zone is typically viable and will heal spontaneously. However, prolonged inflammation or infection can impair healing and lead to scar formation.

The depth of the burn injury is classified into four categories:

• Superficial Burns (First-Degree Burns): Involve damage to the epidermis only. These burns are characterized by redness, pain, and dryness, but without blisters. Healing typically occurs within a few days without scarring.
• Partial-Thickness Burns (Second-Degree Burns): Involve damage to the epidermis and part of the dermis. These burns are characterized by blisters, pain, and a moist appearance. Superficial partial-thickness burns heal within 1-3 weeks with minimal scarring, while deep partial-thickness burns take longer to heal (3-8 weeks) and may result in significant scarring.
• Full-Thickness Burns (Third-Degree Burns): Involve damage to the epidermis and the entire dermis. These burns are characterized by a dry, leathery appearance and are often painless due to nerve damage. Full-thickness burns require surgical intervention, such as skin grafting, for wound closure.
• Fourth-Degree Burns: Involve damage extending through the skin and into underlying tissues, such as muscle, bone, or tendons. These burns require extensive surgical reconstruction and may result in significant functional impairment.

The type of tissue involved also influences the healing process. Burns affecting areas with limited blood supply, such as tendons, ligaments, and cartilage, are at higher risk of delayed healing and complications. Furthermore, burns involving specialized tissues, such as the face, hands, and joints, require specialized care to optimize functional and aesthetic outcomes.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

3. Biological Processes of Tissue Healing and Regeneration

Wound healing is a complex and dynamic process involving a coordinated sequence of cellular and molecular events. This process can be divided into four overlapping phases: hemostasis, inflammation, proliferation, and remodeling. However, burn wounds have reduced capacity to undergo regeneration and the body will focus on tissue repair.

• Hemostasis: The initial phase of wound healing is hemostasis, which involves the cessation of bleeding through vasoconstriction, platelet aggregation, and clot formation. Platelets release growth factors and cytokines that initiate the inflammatory response and promote cell migration.
• Inflammation: The inflammatory phase is characterized by the infiltration of neutrophils and macrophages into the wound site. Neutrophils clear debris and bacteria, while macrophages phagocytose cellular debris, release growth factors, and stimulate angiogenesis and fibroblast proliferation. While essential for wound healing, excessive or prolonged inflammation can impair tissue repair and lead to scar formation.
• Proliferation: The proliferative phase involves the formation of new tissue to fill the wound defect. This phase is characterized by angiogenesis (formation of new blood vessels), fibroplasia (proliferation of fibroblasts and deposition of extracellular matrix), and epithelialization (migration of epithelial cells to cover the wound surface). Growth factors, such as vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-β), play a crucial role in regulating these processes.
• Remodeling: The remodeling phase is the final stage of wound healing, during which the newly formed collagen matrix is reorganized and remodeled. This process involves the degradation of collagen by matrix metalloproteinases (MMPs) and the synthesis of new collagen. The remodeling phase can last for several months to years, and the resulting scar tissue may differ in structure and function from the original tissue.

In burn injuries, the normal wound healing process is often disrupted. Extensive tissue damage, impaired microcirculation, and infection can lead to delayed healing, chronic inflammation, and excessive scar formation. Keloid scars, which extend beyond the original wound boundaries, and hypertrophic scars, which are raised and thickened but remain within the wound boundaries, are common complications of burn injuries. These scars can cause significant functional and aesthetic problems and are often difficult to treat.

In regeneration, tissue is replaced to look identical to the tissue it is replacing. This is possible in very young animals, such as salamanders, however in adult human beings it is not possible in tissues affected by a burn.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

4. Methods for Assessing Tissue Viability

Accurate assessment of tissue viability is essential for guiding clinical decision-making in burn wound management. Several methods are available for assessing tissue viability, ranging from traditional clinical assessment to advanced imaging techniques and biomarkers.

4.1. Clinical Assessment

Clinical assessment, based on visual inspection and tactile examination, is the traditional method for evaluating tissue viability. The clinician assesses the wound for color, capillary refill, sensation, and presence of blisters or eschar. Viable tissue is typically pink or red, with brisk capillary refill and intact sensation. Non-viable tissue is often white, gray, or black, with absent capillary refill and diminished sensation. However, clinical assessment is subjective and can be unreliable, particularly in the early stages after injury when inflammation and edema can obscure the underlying tissue. Furthermore, clinical assessment is limited in its ability to assess the depth of burn injury accurately. This is the basis for the development of tools such as the DeepView system which attempts to improve on the standard visual assessments.

4.2. Laser Doppler Imaging (LDI)

Laser Doppler imaging (LDI) is a non-invasive technique that measures cutaneous blood flow by detecting changes in the frequency of light reflected from moving red blood cells. LDI can provide a quantitative assessment of tissue perfusion, which is an indicator of tissue viability. LDI has been shown to be useful in predicting wound healing potential and in guiding debridement strategies. However, LDI is sensitive to motion artifact and can be affected by edema and eschar. Additionally, LDI provides only a superficial assessment of tissue perfusion and may not accurately reflect the viability of deeper tissues.

4.3. Indocyanine Green (ICG) Angiography

Indocyanine green (ICG) angiography is a technique that uses a fluorescent dye (ICG) to visualize blood vessels and assess tissue perfusion. ICG is injected intravenously, and a near-infrared camera is used to capture images of the vasculature. ICG angiography can provide a more detailed assessment of tissue perfusion than LDI, particularly in deeper tissues. ICG angiography has been used to assess the viability of skin grafts and flaps, as well as to guide surgical debridement in burn wounds. However, ICG angiography is an invasive technique that requires the injection of a dye, which can cause allergic reactions in some patients.

4.4. Spectroscopy

Spectroscopic techniques, such as hyperspectral imaging (HSI) and near-infrared spectroscopy (NIRS), measure the interaction of light with tissue to assess its biochemical composition and physiological state. HSI acquires images at multiple wavelengths, providing information about tissue oxygenation, hemoglobin concentration, and water content. NIRS measures the absorption and scattering of near-infrared light by tissue to assess tissue oxygenation and blood flow. Spectroscopic techniques are non-invasive and can provide a wealth of information about tissue viability. However, they require specialized equipment and expertise in data analysis.

4.5. DeepView System

The DeepView system, as described in the context of this report, utilizes advanced imaging and analysis techniques to identify non-healing tissue in burn wounds. This system likely incorporates features from some of the modalities mentioned above (e.g., spectroscopy, LDI) and combines them with sophisticated algorithms to provide an objective and quantitative assessment of wound healing progress. The key advantage of such a system is the potential to reduce subjectivity in clinical decision-making and to provide early identification of non-viable tissue, allowing for timely intervention and improved outcomes. The precise mechanism of the DeepView system should be further investigated. It is also important to validate its performance in clinical trials and compare it to other methods for assessing tissue viability.

4.6. Biomarkers

Biomarkers are measurable indicators of a biological state or condition. Several biomarkers have been investigated for their potential to predict wound healing outcomes and assess tissue viability in burn injuries. These include inflammatory cytokines (e.g., IL-6, TNF-α), growth factors (e.g., VEGF, TGF-β), and matrix metalloproteinases (MMPs). Elevated levels of inflammatory cytokines are associated with delayed wound healing and scar formation, while increased levels of growth factors are associated with improved tissue repair. MMPs play a crucial role in collagen remodeling, and their activity is tightly regulated during wound healing. Analyzing the levels of these biomarkers in wound fluid or tissue samples can provide valuable information about the wound healing environment and guide treatment strategies. However, the use of biomarkers in clinical practice is still limited, and further research is needed to identify and validate reliable biomarkers for assessing tissue viability in burn injuries.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

5. Regenerative Medicine Approaches to Enhance Tissue Repair

Regenerative medicine holds great promise for enhancing tissue repair and reducing scarring in burn injuries. These approaches aim to stimulate the body’s natural healing capabilities through the application of growth factors, cell-based therapies, and biomaterials. These methods aim to speed up the repair process because the body cannot undergo true regeneration.

5.1. Growth Factors

Growth factors are naturally occurring proteins that regulate cell proliferation, differentiation, and migration. Several growth factors have been shown to promote wound healing in burn injuries, including epidermal growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). Topical application of growth factors can stimulate keratinocyte proliferation and migration, promote angiogenesis, and enhance collagen synthesis. Several growth factor-based products are commercially available for the treatment of chronic wounds, including burn wounds. However, the efficacy of these products varies depending on the type of growth factor, the delivery method, and the wound characteristics. Furthermore, the long-term safety of growth factor therapy needs to be carefully evaluated.

5.2. Cell-Based Therapies

Cell-based therapies involve the transplantation of cells into the wound site to promote tissue repair and regeneration. Several types of cells have been investigated for their potential to enhance wound healing in burn injuries, including keratinocytes, fibroblasts, mesenchymal stem cells (MSCs), and endothelial progenitor cells (EPCs). Keratinocytes are the primary cells of the epidermis and are essential for epithelialization. Cultured epidermal autografts (CEAs) are widely used for the treatment of extensive burn injuries. However, CEAs are fragile and prone to contraction, resulting in poor cosmetic outcomes. Fibroblasts are the main cells responsible for collagen synthesis and extracellular matrix deposition. Transplantation of fibroblasts can promote collagen synthesis and improve wound healing. MSCs are multipotent stem cells that can differentiate into various cell types, including fibroblasts, osteoblasts, and adipocytes. MSCs have been shown to promote wound healing through paracrine mechanisms, by releasing growth factors and cytokines that stimulate cell proliferation, angiogenesis, and collagen synthesis. EPCs are precursor cells that can differentiate into endothelial cells, which are the cells that line blood vessels. Transplantation of EPCs can promote angiogenesis and improve tissue perfusion in burn wounds. Cell-based therapies have shown promising results in preclinical studies and clinical trials. However, the optimal cell type, delivery method, and dosage remain to be determined.

5.3. Biomaterials

Biomaterials are materials that are designed to interact with biological systems. Several types of biomaterials have been developed for wound healing applications, including scaffolds, hydrogels, and wound dressings. Scaffolds provide a three-dimensional structure that supports cell attachment, proliferation, and differentiation. Scaffolds can be made from various materials, including collagen, hyaluronic acid, chitosan, and synthetic polymers. Hydrogels are water-based polymers that can absorb large amounts of water and provide a moist environment that promotes wound healing. Wound dressings protect the wound from infection, absorb exudate, and promote epithelialization. Biomaterials can be used to deliver growth factors, cells, or other therapeutic agents to the wound site. They can also be designed to degrade over time, releasing their contents and promoting tissue regeneration. Biomaterials have shown great promise for enhancing wound healing in burn injuries, and several biomaterial-based products are commercially available.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

6. Challenges and Future Directions

Despite significant advances in burn wound management, several challenges remain. Accurate assessment of tissue viability remains a challenge, particularly in the early stages after injury. The subjective nature of clinical assessment and the limitations of current imaging techniques highlight the need for more objective and quantitative methods for assessing tissue perfusion and cellular function. The DeepView system and similar emerging technologies offer a promising approach to address this need, but further research is needed to validate their performance and optimize their clinical use.

Regenerative medicine approaches hold great promise for enhancing tissue repair and reducing scarring in burn injuries. However, several challenges need to be addressed before these approaches can be widely implemented in clinical practice. These include the high cost of cell-based therapies, the difficulty in scaling up cell production, and the potential for immune rejection. Furthermore, the long-term safety and efficacy of regenerative medicine therapies need to be carefully evaluated.

Future research should focus on developing more sophisticated imaging techniques for assessing tissue viability, identifying novel biomarkers for predicting wound healing outcomes, and optimizing regenerative medicine therapies for burn injuries. Furthermore, there is a need for more collaborative research involving clinicians, engineers, and scientists to develop innovative solutions for burn wound management.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

7. Conclusion

Burn injuries pose a significant clinical challenge, leading to extensive tissue damage and impaired healing. Accurate assessment of tissue viability is crucial for guiding clinical decision-making and optimizing treatment strategies. Traditional clinical assessment methods are subjective and can be unreliable, leading to the development of advanced imaging techniques and biomarkers. The DeepView system, which uses advanced imaging to identify non-healing tissue in burn wounds, shows potential for improving wound assessment. Regenerative medicine approaches, such as growth factors, cell-based therapies, and biomaterials, offer promising avenues for enhancing tissue repair and reducing scarring in burn injuries. Further research is needed to overcome the challenges associated with these approaches and to translate them into clinical practice. Continued innovation and collaboration are essential for improving outcomes for burn patients.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

References

• American Burn Association. (2018). Burn Incidence and Treatment in the US: 2018 Fact Sheet. Chicago, IL.
• Atiyeh, B. S., Costagliola, M., Hayek, S. N., & Dibo, S. A. (2005). Wound healing in diabetes mellitus. International Journal of Burns and Trauma, 5(1), 1-10.
• Demling, R. H. (2008). Burns. The New England Journal of Medicine, 359(17), 1803-1811.
• Finnerty, C. C., Jeschke, M. G., Herndon, D. N., & Arnoldo, B. A. (2013). Burn-induced hypermetabolism and metabolic support. The Lancet, 382(9902), 1423-1432.
• Gauglitz, G. G., Williams, F. N., Herndon, D. N., & Jeschke, M. G. (2011). Burn scar contractures. Burns, 37(1), 49-61.
• Greenhalgh, D. G. (2003). Burn resuscitation. Critical Care Medicine, 31(1 Suppl), S24-S31.
• Hee, C. K., et al. (2017). Review of Laser Doppler Imaging for the Assessment of Burn Wounds. Journal of Burn Care & Research, 38(6), 368-378.
• Kim, J. H., et al. (2018). Indocyanine green angiography for the evaluation of skin grafts and flaps. Archives of Plastic Surgery, 45(2), 95-102.
• Singer, A. J., & McClain, S. A. (1999). Cutaneous wound healing. The New England Journal of Medicine, 341(10), 738-746.
• Tredget, E. E., Levi, B., & Donelan, K. (2014). Biology of scar formation, scar management, and future directions. Eaesthetic Plastic Surgery, 38(6), 1063-1075.
• van Zuijlen, P. P. M., et al. (2003). Reliability of clinical assessment of burn depth. Burns, 29(1), 2-6.
• Watkins, P. E., et al. (2017). A review of the application of stem cells in burn wound healing. Stem Cell Research & Therapy, 8(1), 153.
• Wilkinson, H. N. (2014). Biomaterials for wound healing. Advanced Drug Delivery Reviews, 79-80, 3-17.
• Yao, Y., et al. (2017). Hyperspectral imaging for burn wound assessment: a review. Journal of Biomedical Optics, 22(11), 111414.